» Articles » PMID: 14715827

Two Prevalent CYP17 Mutations and Genotype-phenotype Correlations in 24 Brazilian Patients with 17-hydroxylase Deficiency

Overview
Specialty Endocrinology
Date 2004 Jan 13
PMID 14715827
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

We performed molecular genetic analysis of 24 subjects from 19 families with 17-hydroxylase deficiency in Brazil. Of 7 novel CYP17 mutations, 2 (W406R and R362C) account for 50% and 32% of the mutant alleles, respectively. Both mutations were completely inactive when studied in COS-7 cells and yeast microsomes; however, phenotypic features varied among subjects. Some 46,XY individuals with these genotypes had ambiguous genitalia, and other subjects had normal blood pressure and/or serum potassium. We found mutations W406R and R362C principally in families with Spanish and Portuguese ancestry, respectively, suggesting that two independent founder effects contribute to the increased prevalence of 17-hydroxylase deficiency in Brazil. Mutations Y329D and P428L retained a trace of activity, yet the two individuals with these mutations had severe hypertension and hypokalemia. The 46,XX female with mutation Y329D reached Tanner stage 5, whereas the 46,XY subject with mutation P428L remained sexually infantile. The severity of hypertension, hypokalemia, 17-deoxysteroid excess, and sex steroid deficiency varied, even among patients with completely inactive CYP17 protein(s). Spontaneous sexual development occurred only in 46,XX females with partial deficiencies. We conclude that other factors, in addition to CYP17 genotype, contribute to the phenotype of individual patients with 17-hydroxylase deficiency.

Citing Articles

Rare Types of Congenital Adrenal Hyperplasias Other Than 21-hydroxylase Deficiency.

Isakoca M, Erdeve S, Cetinkaya S J Clin Res Pediatr Endocrinol. 2024; 17(Suppl 1):23-32.

PMID: 39713884 PMC: 11730102. DOI: 10.4274/jcrpe.galenos.2024.2024-6-21-S.


17α Hydroxylase/17,20 lyase deficiency: clinical features and genetic insights from a large Turkey cohort.

Siklar Z, Camtosun E, Bolu S, Yildiz M, Akinci A, Bas F Endocrine. 2024; 85(3):1407-1416.

PMID: 39020240 PMC: 11316693. DOI: 10.1007/s12020-024-03962-6.


Successful Pregnancy in Isolated 17,20-lyase Deficiency Without Glucocorticoid Use or Assisted Reproduction Techniques.

Oliveira J, Genari C, Sobral P, Kater C, Costa-Barbosa F JCEM Case Rep. 2024; 2(6):luae100.

PMID: 38933733 PMC: 11203905. DOI: 10.1210/jcemcr/luae100.


17α-hydroxylase/17,20-lyase Deficiency Diagnosed at 45 Years of Age with Hyperaldosteronism.

Ikeya A, Yamashita M, Kakizawa K, Kawauchi Y, Matsushita A, Fujisawa Y Intern Med. 2024; 63(22):3071-3076.

PMID: 38599871 PMC: 11637798. DOI: 10.2169/internalmedicine.3084-23.


Clinical Features of Unrecognized Congenital Adrenal Hyperplasia Due to 17α-hydroxylase Deficiency Since Adolescence: A Case Report.

Rashmi K, Ravichandran L, Roy A, Naik D, Kamalanathan S, Sahoo J J ASEAN Fed Endocr Soc. 2023; 38(2):131-134.

PMID: 38045661 PMC: 10692439. DOI: 10.15605/jafes.038.02.08.